Celgene Corp Drug Patent Portfolio

Celgene Corp's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Celgene Corp News

Experts provide insights on the implications of the US antitrust legal action concerning cancer medication Revlimid for Dr. Reddy's

19 Mar, 2024

See More